Top Houston, TX Biotech Startups (43)
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
Aviara is the development of small molecule integrin inhibitors that modulate the activity.
Biostate AI's mission is to develop generative AI that can benefit all of human health. We observe that biological beings are dynamic systems, with each individual slightly different today vs. yesterday or tomorrow. 🎁 Promotional RNAseq service for Academia: $10K Worth of RNAseq, Now Just $6K (or value of $10,000). Contact us: [email protected]
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
At Solugen, we believe planet-scale change starts with the chemistry we use every day. So we’ve built the world’s first clean molecule factory. Fusing biology with chemistry and technology to make the materials we need to sustain life on Earth. We’re pioneering the way to scale synbio. One that uses evolved enzymes, plant-based feedstocks and clean, catalytic reactions to make 90%...
Volumetric is an advanced biomaterials and biofabrication company.
Glycos Biotechnologies is an International biochemical company commercializing sustainable chemicals made from renewable feedstocks.
Moleculin is a pharmaceutical company developing dermatological products to treat skin disorders.
Pulmotect develops products that boost the innate immune system to protect against a wide range of lung infections.
CellTexTherapeutics is an adult stem cell laboratory that operates a bank to store adult stem cells for medical treatments.
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory...
Founded in 2018, Sandhill Therapeutics has harnessed the power of Natural Killer (NK) cells and innate T cell populations to maximize tumor killing and to provide a cost-effective, universal, cellular immuno-oncology therapy.
BioGenix grew out of the recognition of the important potential of regenerative medicine in giving hope to patients who suffer from past injuries, chronic conditions, or degenerative disease. Out of this potential grew the demand for safe, reliable, ethically sound regenerative products -- and BioGenix was up to the task. Working directly with hospitals participating in umbilical cord tissue donation programs...
Gene by Gene offers a wide range of affordable genetic testing lab services using cutting-edge biotechnology, giving unparalleled insight into ourselves and our future.
Endothelix, Inc. is a cardiovascular device company based in Houston, Texas and is focused on non-invasive vascular function measurement.
DNAtrix is a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer. DNAtrix’s lead product, DNX-2401, is a modified common cold virus that targets and kills cancer cells selectively.
Accelerate and transform discovery research and capitalize on the diverse opportunities of the microbiome with Diversigen. Diversigen provides comprehensive fee-for-service microbiome and metagenomics services focused on solutions to improve human, animal, and environmental health. Diversigen is at the forefront of setting industry standards for quality with a microbiome CLIA/CAP accredited, GLP compliant laboratory. Diversigen has extensive experience with highly diverse microbiome sample...
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, we strike cancer at its core by engineering cell therapies that target neoantigens arising from genomic mutations. We have developed proprietary, rapid, cost-effective solutions to deliver tumor-specific killer T cells to large cancer...
